[Visceral calcinosis induced by intravenous phosphate perfusions in myelomatous hypercalcemia].
D001536:Bence Jones Protein / Q000097:blood; D002114:Calcinosis / Q000139:chemically induced* / Q000473:pathology / Q000628:therapy; D002118:Calcium / Q000378:metabolism; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D006934:Hypercalcemia / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D007684:Kidney Tubules / Q000473:pathology; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D010477:Perfusion; D010710:Phosphates / Q000008:administration & dosage / Q000009:adverse effects*; D011650:Pulmonary Alveoli / Q000473:pathology
D010710:Phosphates; D003520:Cyclophosphamide; D001536:Bence Jones Protein; D008558:Melphalan; D002118:Calcium
Calcinose viscérale induite par les perfusions de phosphate dans une hypercalcémie myélomateuse.